
Independent pharmacies adapt to specialty drugs, biosimilars, cold-chain, and REMS demands.
Fougera and Protherics announce increased DigiFab production to counteract shortage.
Fougera and Protherics, Inc. have announced an increase in production of their digoxin immune fab (ovine) (





